Agenda

Return

C.122

To:	Board of Supervisors
From:	William Walker, M.D., Health Services
Date:	January 8, 2013

Contra

Costa

County

Subject:

CHANGE ORDER TO PURCHASE ORDER WITH POLYMEDCO

APPROVE	OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR	RECOMMENDATION OF BOARD COMMITTEE

Action of Board On: 01/08/2013

APPROVED AS RECOMMENDED

OTHER

Clerks Notes:

VOTE OF SUPERVISORS

AYE:

John Gioia, District I Supervisor
Candace Andersen, District II Supervisor
Mary N. Piepho, District III Supervisor
Karen Mitchoff, District IV Supervisor
Federal D. Glover, District V Supervisor

Contact:	Anna Roth 370-5101
cc:	J Pigg Margaret Harris D Gary

I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED: January 8, 2013
David Twa,

BY:	, Deputy

RECOMMENDATION(S):

Approve and authorize the Purchasing Agent, on behalf of the Health Services Department, to execute a change order to purchase order #F26646 with Polymedco to add $150,000 to a new total of $544,358, for the period from December 1, 2009 through November 30, 2013, for reagents and supplies to perform immunochemical fecal occult blood testing.

FISCAL IMPACT:

The total cost of $544,358 is funded by Enterprise Fund I.

BACKGROUND:

Polymedco’s OC-Auto Micro 80 Analyzer with FOBT-CHECKOC Reagents is an automated immunochemical fecal occult blood testing system that detects human red cells only with no interferences from red meat, turnips, melons, aspirin, anti-inflammatory drugs and Vitamin C. This improvement directs many more of the “right” patients to colonoscopy leading to the earlier detection of polyps and colorectal cancer. Other advantages include: 1) The collection kit is simpler to use than the guaic card. 2) This methodology requires only one sample compared to 3 samples of guaic, resulting in a higher patient compliance rate. 3) There are no dietary restrictions as this is specific for human hemoglobin.

BACKGROUND: (CONT'D)

The U.S. Preventive Services Task Force recommends that adults age 50 to 75 be screened for colorectal cancer using annual high-sensitivity fecal occult blood testing, sigmoidoscopy every 5 years with fecal occult testing between sigmoidoscopic exams, or colonoscopy every 10 years. Recently, the American Cancer Society and Multisociety Task Force on Colorectal Cancer also endorsed Fecal Occult Blood Testing by immunohistochemical methods for colon cancer screening. The CCRMC gastrointestinal specialists, internal medicine physicians as well as utilization review and PCPC Committees Strongly endorse this test. Fecal Occult Blood testing has become the community standard as both Kaiser and John Muir systems have converted to Polymedco’s OC-Auto Micro 80 testing.

CONSEQUENCE OF NEGATIVE ACTION:

If this contract is not approved, The CCRMC Clinical Laboratory will not be able to perform patient testing for colorectal cancer.

CHILDREN'S IMPACT STATEMENT:

No impact.